Development
NeuroOne Medical Technologies Corporation
NMTC
$0.5817
-$0.0073-1.24%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.34M | -3.14M | -3.47M | -3.52M | -1.73M |
| Total Depreciation and Amortization | 58.70K | 62.50K | 57.00K | 43.90K | 35.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 337.50K | 331.70K | 319.50K | 244.50K | 306.20K |
| Change in Net Operating Assets | -860.60K | -161.90K | 152.00K | -317.10K | -2.10M |
| Cash from Operations | -3.81M | -2.90M | -2.94M | -3.55M | -3.49M |
| Capital Expenditure | -37.10K | -57.60K | -139.30K | -175.70K | -11.50K |
| Sale of Property, Plant, and Equipment | -- | 7.50K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 1.00M | 2.00M | 26.60K |
| Cash from Investing | -37.10K | -50.10K | 860.70K | 1.82M | 15.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.26M | 6.04M | 1.62M | 928.30K | -- |
| Repurchase of Common Stock | -13.60K | -8.60K | -12.20K | -98.70K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -37.70K | -836.90K | -51.40K | -167.60K | -15.70K |
| Cash from Financing | 1.21M | 5.19M | 1.56M | 662.00K | -15.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.64M | 2.24M | -518.70K | -1.07M | -3.49M |